Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Akerblom

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Immunology|August 1, 1991
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodiesP A Broliden, B Mäkitalo, L Akerblom, et al.
The Journal of General Virology|December 1, 1992
Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120A Bolmstedt, S Olofsson, E Sjögren-Jansson, et al.
Archives of Virology|January 1, 1994
Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4G J Gram, A Hemming, A Bolmstedt, et al.
AIDS (London, England)|October 1, 1990
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120L Akerblom, J Hinkula, P A Broliden, et al.
AIDS Research and Human Retroviruses|August 25, 2000
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypesA S Rytting, L Akerblom, J Albert, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccineP Putkonen, E Björling, L Akerblom, et al.
The Journal of General Virology|May 1, 1993
Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escapeM Arendrup, A Sönnerborg, B Svennerholm, et al.
Age and Ageing|March 20, 2008
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic eldersJennifer L Akerblom, Rosann Costa, Jose A Luchsinger, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Vaccine|November 1, 1994
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccinesP de Vries, J L Heeney, J Boes, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Immunology|August 1, 1991
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodiesP A Broliden, B Mäkitalo, L Akerblom, et al.
The Journal of General Virology|December 1, 1992
Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120A Bolmstedt, S Olofsson, E Sjögren-Jansson, et al.
Archives of Virology|January 1, 1994
Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4G J Gram, A Hemming, A Bolmstedt, et al.
AIDS (London, England)|October 1, 1990
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120L Akerblom, J Hinkula, P A Broliden, et al.
AIDS Research and Human Retroviruses|August 25, 2000
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypesA S Rytting, L Akerblom, J Albert, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccineP Putkonen, E Björling, L Akerblom, et al.
The Journal of General Virology|May 1, 1993
Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escapeM Arendrup, A Sönnerborg, B Svennerholm, et al.
Age and Ageing|March 20, 2008
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic eldersJennifer L Akerblom, Rosann Costa, Jose A Luchsinger, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Vaccine|November 1, 1994
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccinesP de Vries, J L Heeney, J Boes, et al.
Pageof 5